Artificial intelligence is growing fast across the world, and healthcare is one of the main areas where it is being used. One of the most exciting areas is using AI to find cancer early. Over the last few years, researchers have looked closely at this, and its use has grown a lot.
AI has become a really helpful tool for doctors because it can spot tiny patterns and hidden problems in medical data. This helps doctors catch and treat cancer early, giving patients a much better chance and helping doctors fight the disease.
How is AI Used in Cancer Therapy?
Old ways of finding cancer, like reading biopsy samples and looking at lab reports, take a lot of time and can sometimes make human mistakes. On the other hand, AI can look at imaging scans much faster and with greater accuracy.
When it comes to mammograms, AI can make breast images clearer, so radiologists can see the body's structures more easily. It can also figure out the size and shape of a tumor and spot details that a human might miss right away.
AI can also be used instead of old methods to confirm or rule out cancer. For example, a man found a lump in his thyroid and was told he needed a biopsy after an ultrasound looked concerning. He wanted a second opinion from a radiologist who used AI for thyroid ultrasounds to get a clearer picture. That second scan showed the lump was actually not cancer. If he had gone to that AI-assisted doctor first, he could have skipped the biopsy entirely and reached the same safe result.
“Because AI models are trained on massive amounts of data, they have a much larger library of examples to learn from. They are great at finding tiny patterns in imaging scans that human eyes might miss, helping doctors catch and treat cancer early.”
- Dr. Parveen Yadav
Treatment Planning With AI
Artificial intelligence also helps doctors plan cancer treatments better. Usually, treating cancer involves a lot of trial and error. Since every patient is unique, different people respond to treatments in different ways. Machine learning can look at past cases and use a patient's medical history, lifestyle, and genetic data to guess how they might react to a specific treatment.
Researchers at the National Institutes of Health created an AI tool that studies individual cells inside a tumor to predict if the cancer will respond to a certain drug. Doctors usually use bulk sequencing, which looks at the average genetic makeup of all the cells in a tumor sample combined.
However, tumors contain different groups of cells called clones that can react differently to treatments. Single-cell RNA sequencing looks at individual cells to help doctors find out which cells might resist treatment so they can change their plan. AI can use bulk RNA data and single-cell data together to figure out how cancer cells will react to targeted drugs or drug combinations.
AI also speeds up how cancer drugs are discovered. Researchers at the National Cancer Institute use AI to predict how immune cells, known as T cells, will respond to tumors. They have built predictive AI models using deep learning to create a map of common pathways for how drugs work.
Benefits of AI in Early Cancer Detection
The biggest benefit of using AI for cancer detection is speed. A radiologist might take twenty to thirty minutes to carefully review a single scan, but an AI tool can flag areas of concern in seconds. This doesn't replace the doctor's judgment, but it does mean doctors can prioritize scans that need urgent attention and spend more time on complex cases instead of routine reviews.
AI also helps close gaps in access to specialist care. In many parts of the world, there simply aren't enough radiologists or oncologists to review every scan carefully. AI tools can act as a second set of eyes in these settings, flagging suspicious cases for a specialist to look at more closely, even in hospitals that don't have an on-site expert available around the clock.
Cost is another factor. Fewer unnecessary biopsies, like in the thyroid example above, mean lower costs for patients and less strain on healthcare systems. When AI can confirm a lump is likely benign without an invasive procedure, everyone benefits, the patient avoids unnecessary pain and risk, and the hospital saves resources for patients who actually need intervention.
Challenges and Limitations of AI in Cancer Care
Despite these advances, AI isn't perfect, and it isn't meant to work alone. One of the biggest challenges is the quality of the data used to train these models. If an AI system is trained mostly on scans from one population group, it may not perform as accurately for patients from different backgrounds. Researchers are working to build more diverse datasets, but this remains an ongoing concern.
False positives and false negatives are also a real risk. An AI tool might flag something as suspicious that turns out to be harmless, leading to unnecessary anxiety and follow-up tests. Or, in rarer cases, it could miss something a human doctor would have caught. This is exactly why AI is used to support doctors, not replace them. Every AI-flagged result still needs a trained specialist to confirm it.
There are also questions around regulation and accountability. As more AI tools enter clinical use, health authorities need clear standards for how these tools are tested, approved, and monitored over time. Patient data privacy is another important piece of this conversation, since these models rely on large amounts of sensitive medical information to work well.
What Does AI in Cancer Care Mean for Patients?
For patients, the growing use of AI in cancer care means earlier answers, fewer unnecessary procedures, and treatment plans built around their specific biology rather than a one-size-fits-all approach. It doesn't mean handing decisions over to a machine, it means doctors have a more powerful tool to work with, backed by patterns drawn from millions of data points no single physician could review alone.
As these tools continue to improve, the technology is moving toward things like blood tests that can screen for multiple cancers at once, and AI systems that work alongside electronic health records to flag risk factors before symptoms even appear. The goal isn't to replace the doctor-patient relationship, but to give both sides more time and better information to work with.
Conclusion
So, can AI detect cancer earlier than traditional methods? In many cases, yes but the real value isn't AI working in isolation. It's AI and human expertise working together, each covering the other's blind spots. As adoption grows and these tools become more refined, that partnership is likely to become the standard, not the exception, in how cancer is diagnosed and treated.
Article by Dr. Parveen Yadav
Chairperson - Surgical Oncology & Thoracic Surgery
Artemis Hospitals